S. C. Mathew et al. / Bioorg. Med. Chem. Lett. 19 (2009) 6736–6739
7. Faden, A. I.; Holaday, J. W. Science 1979, 205, 317.
6739
la Méditerranée, Faculté de Médecine, Assistance Publique des
Hôpitaux de Marseille, Fondation Mérieux and Conseil Régional
Provence Alpes Côte d’Azur for fundings; Johnson and Johnson lab-
oratories for CHO K1 cells supply and Conseil Général des Bouches
du Rhône are also gratefully acknowledged; Drs T. Meert and van
Hijfte, and Miss De Chabanne for helpful suggestions.
8. Khorasani, M. Z.; Hajizadeh, S.; Fathollahi, Y.; Semnanian, S. Brain Res. 2006,
1084, 61.
9. Fentanyl: Incapacitating Agent. National Institute for Occupational Safety and
Health. Emergency Response Database. August 22, 2008. Retrieved December
31, 2008.
10. Ju, Y.; Kumar, D.; Varma, R. S. J. Org. Chem. 2006, 71, 6697.
11. Boger, D. L.; Patane, M. A.; Zhou, J. J. Am. Chem. Soc. 1994, 116, 8544.
12. Abdel-Magid, A. F.; Carson, K. G.; Harris, B. D.; Maryanoff, C. A.; Shah, R. D. J.
Org. Chem. 1996, 61, 3849.
13. Borch, R. F.; Bernstein, M. D.; Dupont Durst, H. J. Am. Chem. Soc. 1971, 93, 2897.
14. 1H NMR (CDCl3, 300 MHz) d 8.05 (s, 1H), 7.98 (s, 1H), 7.33–7.07 (m, 9H), 6.93
(d, J = 12 Hz, 2H), 5.87 (d, J = 6 Hz, 1H), 5.17 (d, J = 6 Hz, 1H), 4.64–4.58 (m, 2H),
4.49 (s, 1H), 4.42 (br s, 1H), 4.29 (d, J = 6 Hz, 1H), 3.12–3.05 (m, 4H), 2.94–2.82
(m, 4H), 2.01–1.84 (m, 6H), 1.68–1.52 (m, 12H), 0.90 (t, J = 12 Hz, 3H) 13C NMR
(CDCl3, 75 MHz) d 175.1, 170.2, 153.1, 144.6, 136.2, 130.2, 129.4, 129.0, 127.8,
90.3, 85.4, 73.5, 72.8, 58.5, 52.6, 50.4, 49.8, 49.5, 48.4, 33.5, 31.3, 30.8, 28.9,
28.0, 24.1, 21.9, 9.7; HRMS: C39H50N8O5 calcd: [M+H] 711.3904. Found:
711.3919.
15. Salem, A.; Hope, W. Pharmacol. Biochem. Behav. 1997, 57, 671.
16. Michaelson, D. M.; McDowall, G.; Sarne, Y. J. Neurochem. 1984, 43, 614.
17. Silinsky, E. M. J. Physiol. 2004, 558, 389.
18. Cahill, C. M.; White, T. D.; Sawynok, J. J. Pharmacol. Exp. Ther. 1995, 275, 84.
19. Hack, S. P.; Christie, M. J. Crit. Rev. Neurobiol. 2003, 15, 235.
20. Kaster, M. P.; Budni, J.; Santos, A. R.; Rodrigues, A. L. Eur. J. Pharmacol. 2007, 576,
91.
References and notes
1. (a) Portoghese, P. S.; Larson, D. L.; Sayre, L. M.; Yim, C. B.; Ronsisvalle, G.; Tam,
S. W.; Takemori, A. E. J. Med. Chem. 1986, 29, 1855; (b) Jacobson, K. A.; Xie, R.;
Young, L.; Chang, L.; Liang, B. T. J. Biol. Chem. 2000, 275, 30272; (c) Daniels, D. J.;
Kulkarni, A.; Xie, Z.; Bhushan, R. G.; Portoghese, P. S. J. Med. Chem. 2005, 48,
1713; (d) Savini, L.; Campiani, G.; Gaeta, A.; Pellerano, C.; Fattorusso, C.;
Chiasserini, L.; Fedorko, J. M.; Saxena, A. Bioorg. Med. Chem. Lett. 2001, 11, 1779;
(e) Peng, X.; Knapp, B. I.; Bidlack, J. M.; Neumeyer, J. L. J. Med. Chem. 2006, 49,
256; (f) Karellas, P.; McNaughton, M.; Baker, S. P.; Scammells, P. J. J. Med. Chem.
2008, 51, 6128.
2. Aley, K. O.; Levine, J. D. J. Neurosci. 1997, 17, 735.
3. Halimi, G.; Devaux, C.; Clot-Faybesse, O.; Sampol, J.; Legof, L.; Rochat, H.; Guieu,
R. Eur. J. Pharmacol. 2000, 398, 217.
4. (a) Perez, M.; Jorand-Lebrun, C.; Pauwels, P. J.; Pallard, I.; Halazy, S. Bioorg. Med.
Chem. Lett. 1998, 8, 1407; (b) Bhushan, R. G.; Sharma, S. K.; Xie, Z.; Daniels, D. J.;
Portoghese, P. S. J. Med. Chem. 2004, 47, 2969; (c) Meunier, B. Acc. Chem. Res.
2008, 41, 69.
5. Martin, C.; Leone, M.; Viviand, X.; Ayem, M. L.; Guieu, R. Crit. Care Med. 2000,
28, 3198.
21. Guieu, R.; Peragut, J. C.; Roussel, P.; Hassani, H.; Sampieri, F.; Bechis, G.; Gola,
R.; Rochat, H. Pain 1996, 68, 271.
22. Pham, T.; Carrega, L.; Sauze, N.; Fund-Saunier, O.; Devaux, C.; Peragut, J. C.;
Saadjian, A.; Guieu, R. Anesthesiology 2003, 98, 459.
6. Peters, W. P.; Johnson, M. W.; Friedman, P. A.; Mitch, W. E. Lancet 1981, 1, 529.